DirectorsTalk LSE Stock market news, financial, press release, articles and interviews 
“The focus for the next few years is on relatively modest investment and on driving return on assets towards our medium-term target of 20% for each division”. So said Non-Standard ...
Read Article »Home » Hardman Research
Hardman Research
-
Allergy Therapeutics Sales growth well above market average
-
Morses Club Value-added, customer-driven expansion from core
-
City of London Investment Group Perky markets support dividend hike
-
Urban Logistics REIT The staff of life
-
Shield Therapeutics Taking on China
-
UK Housebuilding Sector in 4Q 2019
-
Social infrastructure: RM Secured Direct Lending an alternative alternative
-
Real Estate Credit Investments Delivering on its promises
-
Calculus Capital Limited / Stargrove Pictures Limited UK Creative Content EIS Fund
-
Titon Holdings Electiton
-
B-North Unquoted SME lender with unique proposition
-
Advanced Oncotherapy Proving the accuracy and superiority of minibeams
-
Palace Capital 1H’20 results announced
-
Artificial Solutions Conversational AI leader; customer wins continue
-
Pantheon International Plc History of value added to portfolio by holding Pantheon
-
Diurnal Group Plc Successful DITEST Phase I trial outcome
-
Genedrive Regulatory hurdle leaped: hearing loss assay
-
Incanthera Ltd Realising near-term value in oncology
-
Chamberlin Management actions yield cautious optimism
-
Non-Standard Finance Trading update: understand the accounting
-
Neodecortech Robustly positioned for 2019/20
-
Advanced Oncotherapy FLASH benefits from new US reimbursement
-
Nexus Investments’ Scale-Up Fund
-
Filta Group FY19 trading update
-
Diurnal Group Approaching a number of near-term milestones
-
Shield Therapeutics Plc More choice for clinicians and patients
-
REA Holdings Weak commodity prices dampen road to recovery
-
Surface Transforms Recent major contract wins transform prospects
-
Haydale Graphene Industries Cost savings evident, revenue growth to come
-
PHOENIX COPPER LTD First stage in potential world-class copper mine
-
REAL ESTATE CREDIT INVESTMENTS 7%+ yield from well-secured property debt portfolio
-
ARTIFICIAL SOLUTIONS 2Q’19 results – customer wins, accelerating order intake
-
ADVANCED ONCOTHERAPY Nearing the end goal
-
SHIELD THERAPEUTICS FDA approval opens door to major US opportunity
-
PRIMARY HEALTH PROPERTIES High security and accelerating dividend growth
-
Burford Capital Results don’t need to be appealed
-
Gateley Plc Excellent full-year results
-
ARBUTHNOT BANKING GROUP 1H’19 results: diversified, low-risk growth continues
-
Koovs Plc New year started with a bang
-
City of London Investment Group Finishing ahead in a volatile year for markets
